Eversept Partners’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.7M Sell
924,193
-273,529
-23% -$14.8M 3.54% 10
2025
Q4
$55.3M Sell
1,197,722
-224,261
-16% -$10M 3.1% 9
2025
Q3
$51.2M Buy
1,421,983
+123,469
+10% +$4.09M 3.92% 7
2025
Q2
$42.2M Buy
1,298,514
+741,444
+133% +$24.3M 4.25% 6
2025
Q1
$21M Buy
557,070
+429,482
+337% +$34.3M 2.38% 15
2024
Q4
$10.4M Buy
+127,588
New +$12.7M 1.08% 26
2024
Q3
Sell
-96,089
Closed -$7.26M 79
2024
Q2
$7.26M Sell
96,089
-101,242
-51% -$6.89M 0.56% 36
2024
Q1
$13.5M Sell
197,331
-36,508
-16% -$2.53M 1.01% 22
2023
Q4
$14.7M Buy
233,839
+43,409
+23% +$2.25M 1.44% 19
2023
Q3
$9.71M Sell
190,430
-5,261
-3% -$260K 1.08% 24
2023
Q2
$9.77M Sell
195,691
-103,359
-35% -$4.9M 1.03% 28
2023
Q1
$11.2M Buy
299,050
+120,597
+68% +$5.12M 1.01% 27
2022
Q4
$8.56M Buy
+178,453
New +$7M 0.81% 30

Other funds holding PCVX